DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Safra T, Borgato L, Nicoletto MO. et al.
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.
Mol Cancer Ther 2011;
10: 2000-2007
doi:10.1158/1535-7163.MCT-11-0272
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.